Help us: Donate
Follow us on:



Tag: GlycoSENS

May 02, 2019
Today, we want to highlight a new study that shows, for the first time, that established AGEs can be reversed via therapeutic intervention. What are AGEs? Advanced glycation end products (AGEs) are harmful compounds that are created when proteins or fats combine with sugars in the bloodstream in a process known as glycation. AGEs can...
SENS Research white logo
September 19, 2017
We are pleased to hear that the SENS Research Foundation has announced a new research program in collaboration with the Spiegel lab at Yale University. This new project is a continuation of their joint efforts regarding the crosslink glucosepane and sees them moving towards effective ways to remove it from the body to address age-related...
August 11, 2017
Coming from a fusion of the words ‘protein’ (a molecule that a cell uses as a machine or scaffolding) and ‘stasis’ (meaning to keep the same), the term ‘proteostasis’ can essentially be simplified into “Each function reliant on proteins is running as it should. There are enough proteins to serve a function, and the concentrations...
SENS logo white
June 01, 2017
We have been busy advocating for rejuvenation biotechnology. Elena Milova recently attended the first International Longevity and Cryopreservation Summit in Madrid with a talk about how to deliver the most effective messages to engage the general public to support aging and rejuvenation research. We will shortly have a number of exciting articles about the conference,...
SENS logo white
February 25, 2017
The SENS Research Foundation (SRF) is a 501(c)(3) non-profit organization whose focus is on developing and ensuring widespread access to rejuvenation biotechnologies meant to bring the pathologies of old age under comprehensive medical control. SRF was co-founded in March 2009 by Michael Kope, Dr. Aubrey de Grey, Jeff Hall, Sarah Marr, and Kevin Perrott. The approach to...